From challenges to opportunities, awareness to readiness, explore what Oncidium’s voices have to say about advancing Radiotheranostics Today.
In this issue:
- MIRE: The Real Barriers to RLT Access by Rebecca Lo bue
She introduces a clear framework for understanding why access remains unequal: Money, Infrastructure, Radiopharmaceuticals, Expertise.
- FAPI Theranostics: A New Hope for End-Stage Cancer Patients by Dr. Swagat Dash
Pancreatic, gastric, and cholangiocarcinoma: the cancers where FDG-PET falls short and conventional therapy runs out. Dr Swagat Dash reviews how FAPI ligands, paired with ⁶⁸Ga, ¹⁷⁷Lu, ²²⁵Ac, or ¹⁶¹Tb, are reshaping imaging and therapy by hitting the tumor microenvironment itself.
-
Radiopharmaceuticals: From Specialized Modality to Scalable Global Oncology Powerhouse by Taylor A. Prejna
A 2,000%+ growth in U.S. radiopharmaceutical therapy administrations in just a decade. Multi-billion-dollar acquisitions. Over 300 active clinical trials. The numbers tell a story. Radiopharmaceuticals are no longer a niche.
-
Beyond the Cure: Economic Barriers Limiting Advanced Radionuclide Therapy by Dr. Phumudzo Nemutaduni
What happens when a patient responds beautifully to ¹⁷⁷Lu-PSMA, and then the next dose never arrives?
- Radioligand Therapy Snapshot
-
Situation in Iraq
by Dr. Ali Abdulhasan Kadhim
-
Situation in Canada
by Dr. Patrick Veit-Haibach & Nicolas Rondeau Lapierre
-
-
From Life-Changing Donations to Catalyst of Systemic Change by Dr. Alice Viana & Elisa Cannarozzo
RLT-Connect, our dose donation program, started with Fernando Acosta's fight for radioligand therapy. The logistical, economic, and regulatory barriers it revealed now drive Oncidium's push for systemic change.
-
A Life in Radiotheranostics: A Conversation with Prof. Kalevi Kairemo
What does it take to turn a fringe idea into a therapy that crosses continents? Professor Kalevi Kairemo takes us through four decades of radiotheranostics, from MSKCC labs to the first Lu-177-PSMA treatment in Ghana.
-
Meet Europa Uomo: The European Prostate Cancer Coalition
31 national patient groups. One united European voice. Since 2004, Europa Uomo has worked to ensure that every man facing prostate cancer across Europe gets the screening, treatment, and dignity he deserves.
- What's up Oncidium?
- Patient Sessions Take the Stage to Share Their View
- Launch of the Oncidium Foundation LATAM
- RLT Channel Episode 2: Shedding Light on NET Patients and PRRT
- World Radiotheranostics Day: Raising Awareness to Improve Access
- The Oncidium foundation at the European Parliament
